• CX-5461 Induces Mitotic Catastrophe and Sensitizes Cervical

  2026-05-20

  This study demonstrates that the RNA polymerase I inhibitor CX-5461 impairs cervical cancer cell growth by activating DNA damage responses and triggering mitotic catastrophe, ultimately leading to cell death or senescence. Moreover, CX-5461 enhances cisplatin sensitivity, providing a rationale for its use in treatment-resistant cervical cancer settings.

• Praeruptorin A (SKU N2885): Scenario-Driven Solutions for Ce

  2026-05-20

  This article delivers scenario-based, evidence-backed guidance on using Praeruptorin A (SKU N2885) for cell viability, inflammation, and metastasis assays. By addressing real-world lab challenges, it highlights how this angular pyranocoumarin compound from APExBIO promotes reproducibility, mechanistic clarity, and workflow efficiency in biomedical research.

• Cy5 TSA Fluorescence System Kit: Quantitative Signal Amplifi

  2026-05-19

  The Cy5 TSA Fluorescence System Kit enables robust, horseradish peroxidase catalyzed tyramide deposition, achieving up to 100-fold signal amplification in immunohistochemistry and in situ hybridization. This kit supports rapid, highly specific fluorescent labeling workflows, especially for detecting low-abundance targets.

• Calpeptin’s Role in Extracellular Vesicle Inhibition: A New

  2026-05-19

  Explore how Calpeptin, a potent calpain inhibitor, uniquely enables advanced research into extracellular vesicle release and fibrosis modulation. This article delivers a deep scientific analysis, linking breakthrough cancer findings to pulmonary fibrosis and beyond.

• Shufeng Xingbi Therapy Restores Th1/Th2 Balance in Allergic

  2026-05-18

  The reference study investigates the mechanistic effects of Shufeng Xingbi Therapy (SFXBT) on immune modulation and gut microbiota in a rat model of allergic rhinitis. By integrating immunological and microbiome analyses, the research highlights SFXBT's ability to ameliorate nasal inflammation, rebalance Th1/Th2 cytokine profiles, and alter gut microbial composition—providing new evidence for integrative approaches in allergy research.

• Benzyl-Activated Streptavidin Magnetic Beads in Viral Entry

  2026-05-18

  This thought-leadership article explores the mechanistic rationale, experimental validation, and strategic value of Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) in translational research—bridging foundational molecular capture technologies with cutting-edge viral entry and protein trafficking studies. Drawing from recent advances in HBV-NTCP-CDC42 biology and competitive bead technologies, we provide protocol guidance, benchmarking, and a forward-looking perspective for translational researchers.

• G-15: Precision G Protein-Coupled Estrogen Receptor Antagoni

  2026-05-17

  G-15 empowers researchers to dissect GPR30-mediated estrogen signaling with high specificity, enabling robust analysis of non-genomic estrogen effects in immune, cancer, and neurobiology models. This guide delivers workflow enhancements, troubleshooting, and actionable insights for maximizing experimental reliability with G-15 from APExBIO.

• Optimized hiPSC Platelet Production: Small Molecule-Driven A

  2026-05-16

  This study presents an optimized protocol for generating functional platelets from human induced pluripotent stem cells, emphasizing cost reduction and improved efficiency through strategic use of small molecule modulators. The approach substantially enhances megakaryocyte yield and platelet output, with implications for scalable platelet manufacturing and cell therapy.

• RBMS1 Loss Boosts PD-L1 Blockade Efficacy in Triple-Negative

  2026-05-15

  This study uncovers RBMS1 as a critical regulator of PD-L1 stability in triple-negative breast cancer (TNBC). Loss of RBMS1 impairs PD-L1 glycosylation via destabilization of B4GALT1 mRNA, enhancing anti-tumor immunity and the effectiveness of immune checkpoint blockade, offering a promising new avenue for immunotherapy.

• Dacarbazine: Mechanisms, Benchmarks, and Oncology Protocols

  2026-05-15

  Dacarbazine is a validated antineoplastic chemotherapy drug that induces DNA damage via alkylation, making it central to the treatment of malignant melanoma, Hodgkin lymphoma, and sarcoma. Its efficacy, mechanism, and protocol parameters are established through peer-reviewed research and product documentation.

• BI 2536: Mechanistic Precision for Translational Cancer Rese

  2026-05-14

  Explore how BI 2536, a highly selective PLK1 inhibitor from APExBIO, empowers translational researchers to bridge mechanistic insights and in vitro-to-in vivo validation for advanced cancer drug development. This article delivers an evidence-driven, scenario-based roadmap, integrating key findings from Schwartz’s dissertation and recent workflow literature, while articulating how BI 2536 uniquely enables robust, reproducible drug response evaluation.

• Thiamet G: Applied Workflows for O-GlcNAcase Inhibition in D

  2026-05-14

  Thiamet G stands out as a potent O-GlcNAcase inhibitor, enabling precise control of protein O-GlcNAcylation for advanced disease modeling and mechanistic studies. With robust solubility, cross-model applicability, and literature-backed efficacy, Thiamet G from APExBIO empowers researchers to dissect post-translational modifications and their impact on cellular fate.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-05-13

  This study demonstrates that phenothiazines, including promethazine hydrochloride, enhance macrophage-mediated antibacterial responses by inducing reactive oxygen species (ROS) production and autophagy. These findings offer mechanistic insights for host-directed therapies against intracellular pathogens, with implications for developing new research strategies in immunology and inflammation.

• Optimized hiPSC Platelet Differentiation: Protocol Advances

  2026-05-13

  This study presents a cost-effective, highly efficient protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), leveraging increased embryoid body (EB) input, human platelet lysate supplementation, and small molecule replacement of cytokines. The findings enable scalable, reproducible platelet production, offering translational potential for cell therapy and disease modeling.

• Gamma-linolenic Acid (GLA): Reliable Solutions for Cell-Base

  2026-05-12

  This article addresses real-world laboratory challenges using Gamma-linolenic acid (GLA, SKU C5518) as a data-backed, reproducible agent in cell viability, proliferation, and cytotoxicity assays. By integrating evidence-based Q&A scenarios and workflow insights, researchers and technicians can optimize anti-inflammatory and apoptosis assays while leveraging the quality and reliability of APExBIO-supplied GLA.

15086 records 3/1006 page Previous Next 12345 下5页 Last page